Patents by Inventor Katarina Edsman

Katarina Edsman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220000752
    Abstract: An injectable hyaluronic acid composition including a hyaluronic acid; a local anesthetic selected from the group of amide and ester type local anesthetics or a combination thereof; and an ascorbic acid derivative in an amount which prevents or reduces the effect on the viscosity and/or elastic modulus G? of the composition caused by the local anesthetic upon sterilization by heat. Further, the medical and non-medical, such as cosmetic, use of such a composition, and to a method of manufacturing such a composition.
    Type: Application
    Filed: September 21, 2021
    Publication date: January 6, 2022
    Inventors: Åsa Wiebensjö, Katarina Edsman
  • Patent number: 11154481
    Abstract: An injectable hyaluronic acid composition including a hyaluronic acid; a local anesthetic selected from the group of amide and ester type local anesthetics or a combination thereof; and an ascorbic acid derivative in an amount which prevents or reduces the effect on the viscosity and/or elastic modulus G? of the composition caused by the local anesthetic upon sterilization by heat. Further, the medical and non-medical, such as cosmetic, use of such a composition, and to a method of manufacturing such a composition.
    Type: Grant
    Filed: September 26, 2019
    Date of Patent: October 26, 2021
    Assignee: Q-MED AB
    Inventors: Åsa Wiebensjö, Katarina Edsman
  • Patent number: 10988600
    Abstract: A hyaluronic acid product is comprising a cross-linked hyaluronic acid and one or more cyclodextrin molecules, and further comprising a guest molecule capable of forming a guest-host complex with the aminocyclodextrin molecule acting as a host, wherein the guest molecule is a retinoid, preferably adapalene, or a RAM BA. The hyaluronic acid is cross-linked by ether bonds, and the one or more cyclodextrin molecules are grafted onto the cross-linked hyaluronic acid by amide bonds, preferably using a triazine-based coupling reagent.
    Type: Grant
    Filed: June 20, 2017
    Date of Patent: April 27, 2021
    Assignee: GALDERMA HOLDING SA
    Inventors: Katarina Edsman, Jean-Guy Boiteau
  • Publication number: 20200261343
    Abstract: An injectable hyaluronic acid composition including a hyaluronic acid; a local anesthetic selected from the group of amide and ester type local anesthetics or a combination thereof; and an ascorbic acid derivative in an amount which prevents or reduces the effect on the viscosity and/or elastic modulus G? of the composition caused by the local anesthetic upon sterilization by heat. Further, the medical and non-medical, such as cosmetic, use of such a composition, and to a method of manufacturing such a composition.
    Type: Application
    Filed: September 26, 2019
    Publication date: August 20, 2020
    Applicant: Q-Med AB
    Inventors: Åsa Wiebensjö, Katarina EDSMAN
  • Publication number: 20190233620
    Abstract: A hyaluronic acid product is comprising a cross-linked hyaluronic acid and one or more cyclodextrin molecules, and further comprising a guest molecule capable of forming a guest-host complex with the aminocyclodextrin molecule acting as a host, wherein the guest molecule is a retinoid, preferably adapalene, or a RAM BA. The hyaluronic acid is cross-linked by ether bonds, and the one or more cyclodextrin molecules are grafted onto the cross-linked hyaluronic acid by amide bonds, preferably using a triazine-based coupling reagent.
    Type: Application
    Filed: June 20, 2017
    Publication date: August 1, 2019
    Applicant: GALDERMA S.A.
    Inventors: Katarina EDSMAN, Jean-Guy BOITEAU
  • Publication number: 20190062461
    Abstract: Efficient cross-linking of hyaluronic acid (HA) is provided by a manufacturing process. In the process, HA is activated by an initial cross-linking in an aqueous solution. Unreacted cross-linking agent is removed from the activated HA. Cross-linking of the activated HA is finalized, without addition of any additional cross-linking agent, in a suspension of a liquid precipitating medium and the activated HA in precipitated form. The resulting cross-linked HA products exhibit high effective cross-linker ratio and other favorable properties, making the products useful as implants and in medical and cosmetic surgery.
    Type: Application
    Filed: August 24, 2018
    Publication date: February 28, 2019
    Applicant: GALDERMA S.A.
    Inventors: Morgan KARLSSON, Katarina EDSMAN
  • Publication number: 20190000740
    Abstract: An injectable hyaluronic acid composition including a hyaluronic acid; a local anesthetic selected from the group consisting of amide and ester type local anesthetics or a combination thereof; and an ascorbic acid derivative in an amount which prevents or reduces the effect on the viscosity and/or elastic modulus G? of the composition caused by the local anesthetic upon sterilization by heat. Further, the medical and non-medical, such as cosmetic, use of such a composition, and to a method of manufacturing such a composition.
    Type: Application
    Filed: September 10, 2018
    Publication date: January 3, 2019
    Applicant: Q-Med AB
    Inventors: Åsa WIEBENSJÖ, Katarina Edsman
  • Patent number: 10098961
    Abstract: An injectable hyaluronic acid composition including a hyaluronic acid; a local anesthetic selected from the group of amide and ester type local anesthetics or a combination thereof; and an ascorbic acid derivative in an amount which prevents or reduces the effect on the viscosity and/or elastic modulus G? of the composition caused by the local anesthetic upon sterilization by heat. Further, the medical and non-medical, such as cosmetic, use of such a composition, and a method of manufacturing such a composition.
    Type: Grant
    Filed: February 3, 2012
    Date of Patent: October 16, 2018
    Assignee: Q-MED AB
    Inventors: Åsa Wiebensjö, Katarina Edsman
  • Patent number: 10077320
    Abstract: Efficient cross-linking of hyaluronic acid (HA) is provided by a manufacturing process. In the process, HA is activated by an initial cross-linking in an aqueous solution. Unreacted cross-linking agent is removed from the activated HA. Cross-linking of the activated HA is finalized, without addition of any additional cross-linking agent, in a suspension of a liquid precipitating medium and the activated HA in precipitated form. The resulting cross-linked HA products exhibit high effective cross-linker ratio and other favorable properties, making the products useful as implants and in medical and cosmetic surgery.
    Type: Grant
    Filed: June 5, 2014
    Date of Patent: September 18, 2018
    Assignee: GALDERMA S.A.
    Inventors: Morgan Karlsson, Katarina Edsman
  • Publication number: 20160376382
    Abstract: Efficient cross-linking of hyaluronic acid (HA) is provided by a manufacturing process. In the process, HA is activated by an initial cross-linking in an aqueous solution. Unreacted cross-linking agent is removed from the activated HA. Cross-linking of the activated HA is finalized, without addition of any additional cross-linking agent, in a suspension of a liquid precipitating medium and the activated HA in precipitated form. The resulting cross-linked HA products exhibit high effective cross-linker ratio and other favorable properties, making the products useful as implants and in medical and cosmetic surgery.
    Type: Application
    Filed: June 5, 2014
    Publication date: December 29, 2016
    Applicant: GALDERMA S.A.
    Inventors: Morgan KARLSSON, Katarina EDSMAN
  • Publication number: 20140039061
    Abstract: An injectable hyaluronic acid composition including a hyaluronic acid; a local anesthetic selected from the group of amide and ester type local anesthetics or a combination thereof; and an ascorbic acid derivative in an amount which prevents or reduces the effect on the viscosity and/or elastic modulus G? of the composition caused by the local anesthetic upon sterilization by heat. Further, the medical and non-medical, such as cosmetic, use of such a composition, and a method of manufacturing such a composition.
    Type: Application
    Filed: February 3, 2012
    Publication date: February 6, 2014
    Applicant: Q-MED AB
    Inventors: Åsa Wiebensjö, Katarina Edsman